↓ Skip to main content

Intratympanic gentamicin for Ménière's disease or syndrome

Overview of attention for article published in Cochrane database of systematic reviews, March 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

policy
1 policy source
twitter
2 X users
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
145 Dimensions

Readers on

mendeley
158 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Intratympanic gentamicin for Ménière's disease or syndrome
Published in
Cochrane database of systematic reviews, March 2011
DOI 10.1002/14651858.cd008234.pub2
Pubmed ID
Authors

Bas Pullens, Peter Paul van Benthem

Abstract

Ménière's disease is characterised by three major symptoms: vertigo, deafness and tinnitus, which may be accompanied by aural fullness, all of which are discontinuous and variable in intensity. While discontinuous, these symptoms are synchronous. Intratympanic application of gentamicin, an ototoxic aminoglycoside, is a relatively new ablative treatment for vertigo in Ménière's disease with promising results.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 158 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 <1%
South Africa 1 <1%
Brazil 1 <1%
Unknown 155 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 30 19%
Student > Bachelor 17 11%
Other 14 9%
Student > Postgraduate 14 9%
Researcher 13 8%
Other 35 22%
Unknown 35 22%
Readers by discipline Count As %
Medicine and Dentistry 79 50%
Neuroscience 8 5%
Nursing and Health Professions 6 4%
Agricultural and Biological Sciences 5 3%
Social Sciences 4 3%
Other 15 9%
Unknown 41 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 June 2023.
All research outputs
#4,727,494
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#6,872
of 11,499 outputs
Outputs of similar age
#22,468
of 119,410 outputs
Outputs of similar age from Cochrane database of systematic reviews
#46
of 97 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 119,410 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.